Committee Testimony and Witness Signup
HB1125 - Prescription Drug Monitoring Program – Prescribers of Opioids – Notification Requirement
Health and Government Operations 3/4/2021 1:30:00 PM
As of: 4/26/2024 2:00:53 PM
| Name | Organization | Position | Testimony | Committee |
|---|---|---|---|---|
| Delegate Beitzel, Delegate Beitzel | FAV |
In Person - Oral Testimony |
HGO | |
| Doherty, Daniel | UNF | Opposition to HB 1125 - PDMP - Opioids-Notificatio | HGO | |
| Elliott, Robyn | UNF | 2021 MNA and ACNM HB 1148 House Side.pdf | HGO | |
| Wise, Steve | UNF | HB1125_UNF_MedChi,MDACEP,MDAAP - PDMP - Prescriber | HGO | |
| Hames, Shari | FAV | S.HamesTestimonyHB1125.pdf | HGO | |
| Bennardi, Maryland Department of Health /Office of Governmen | Maryland Dept. of Health | INFO | 5 - HGO - HB 1125 - MDH - LOI.pdf | HGO |
| Burrell, Deborah | Strengthening the Mid-Atlantic Region for Tomorrow/Burrell International Group | FWA | HB 1125 SMART Support with Amendments.pdf | HGO |
| Stevens, Kristin | Strengthening the Mid-Atlantic Region for Tomorrow (SMART) | FWA |
In Person - Oral Testimony HB1125TestimonyPackage-Stevens.pdf |
HGO |
| Knight, Kirk | The Knight Foundation | FAV | HB1125.pdf | HGO |
| Galica, Stephanie | EBSI | FAV | LOS_MD 1125_Beitzel_March 2021.pdf | HGO |
| Woodruff, Jon | Legislative Analysis and Public Policy Association (LAPPA) | INFO | Maryland HB 1125.LAPPA testimony.pdf | HGO |
| Beitzell, Wendell | FAV | LOS HB1125.docx | HGO |